Over the past 12 months, 0 insiders at Marker Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on MRKR: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 24 | Steve ElmsDirector | BUY | 11.1K | $3.20 | $35K |
| Dec 23, 24 | Nea Partners 16, L.p.TenPercentOwner | BUY | 554.3K | $3.20 | $1.8M |
Over the past 12 months, insiders at Marker Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on MRKR, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market MRKR insider purchase in our data was $1.8M by Nea Partners 16, L.p., TenPercentOwner, filed on Dec 23, 24.
0 different insiders at Marker Therapeutics, Inc. filed open-market SEC Form 4 transactions on MRKR over the last 12 months.
InsiderTape plots every MRKR insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Marker Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →